These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25700592)

  • 1. Antithrombotic management of atrial fibrillation in the elderly.
    Edholm K; Ragle N; Rondina MT
    Med Clin North Am; 2015 Mar; 99(2):417-30. PubMed ID: 25700592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching to Direct Anticoagulation or Continued Vitamin-K Antagonists in Frail Patients With Atrial Fibrillation in Whom Vitamin-K Antagonists Are Tolerated?
    Wallentin L; Giugliano RP
    Circulation; 2024 Jan; 149(4):290-292. PubMed ID: 38252742
    [No Abstract]   [Full Text] [Related]  

  • 3. [Making balances between the risks and benefits of pharmacological treatment in dementia, chronic pain and anticoagulation in elderly persons].
    Fernández Domínguez MJ; Hernández Gómez MA; Garrido Barral A; González Moneo MJ
    Aten Primaria; 2018 Nov; 50 Suppl 2(Suppl 2):39-50. PubMed ID: 30563624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for Maintaining Brain Health: The Role of Stroke Risk Factors Unique to Elderly Women.
    Manwani B; Finger C; Lisabeth L
    Stroke; 2022 Aug; 53(8):2662-2672. PubMed ID: 35652344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heartbeat: cardiovascular disease risk and reproductive factors in women.
    Otto CM
    Heart; 2018 Jul; 104(13):1045-1047. PubMed ID: 29895671
    [No Abstract]   [Full Text] [Related]  

  • 6. Atrial fibrillation, comorbidities, stroke, and mortality in real-world clinical practice.
    Boriani G; Mei DA; Imberti JF
    Pol Arch Intern Med; 2024 Mar; 134(3):. PubMed ID: 38533848
    [No Abstract]   [Full Text] [Related]  

  • 7. Future Directions in Atrial Fibrillation Prophylaxis and Risk Stratification.
    Young AM; Strobel RJ; Martin LW
    Ann Thorac Surg; 2024 Jul; 118(1):288-289. PubMed ID: 38272341
    [No Abstract]   [Full Text] [Related]  

  • 8. Erratum: Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach.
    Fernández CS; Formiga F; Camafort M; Rodrigo JM; Díez-Manglano J; Reino AP; Tiberio G; Mostaza JM;
    BMC Cardiovasc Disord; 2015 Nov; 15():157. PubMed ID: 26585166
    [No Abstract]   [Full Text] [Related]  

  • 9. Stroke prevention in atrial fibrillation: a systematic review.
    Lip GY; Lane DA
    JAMA; 2015 May; 313(19):1950-62. PubMed ID: 25988464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors driving anticoagulant selection in patients with atrial fibrillation in the United States.
    Lauffenburger JC; Farley JF; Gehi AK; Rhoney DH; Brookhart MA; Fang G
    Am J Cardiol; 2015 Apr; 115(8):1095-101. PubMed ID: 25724781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs.
    Verheugt FW; Granger CB
    Lancet; 2015 Jul; 386(9990):303-10. PubMed ID: 25777666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation: A major risk factor for cognitive decline.
    Hui DS; Morley JE; Mikolajczak PC; Lee R
    Am Heart J; 2015 Apr; 169(4):448-56. PubMed ID: 25819850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study.
    Chang HY; Zhou M; Tang W; Alexander GC; Singh S
    BMJ; 2015 Apr; 350():h1585. PubMed ID: 25911526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by Age.
    Abe J; Umetsu R; Kato Y; Ueda N; Nakayama Y; Suzuki Y; Suzuki T; Nagasawa H; Kinosada Y; Nakamura M
    Int J Med Sci; 2015; 12(4):312-21. PubMed ID: 25897292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey.
    Potpara TS; Pison L; Larsen TB; Estner H; Madrid A; Blomström-Lundqvist C;
    Europace; 2015 Mar; 17(3):468-72. PubMed ID: 25722478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.
    Xiang W; Zhang J; Liu M; Liu F; Feng X; Wang Y
    Clin Interv Aging; 2015; 10():515-9. PubMed ID: 25767378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.
    Zoppellaro G; Granziera S; Padayattil Jose S; Denas G; Bracco A; Iliceto S; Pengo V
    Expert Opin Drug Saf; 2015 May; 14(5):683-95. PubMed ID: 25803739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality of life of elderly people on oral anticoagulant for atrial fibrillation: VKA versus direct oral anticoagulants].
    Fareau S; Baumstarck K; Farcet A; Molines C; Auquier P; Retornaz F
    Geriatr Psychol Neuropsychiatr Vieil; 2015 Mar; 13(1):45-54. PubMed ID: 25786423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation.
    Shields AM; Lip GY
    J Intern Med; 2015 Jul; 278(1):1-18. PubMed ID: 25758241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The periprocedural management of novel oral anticoagulants in patients with nonvalvular atrial fibrillation: rationale and a summary of the available evidence from phase 3 clinical trials.
    Krishnamoorthy A; Sherwood MW; Lopes RD; Becker RC
    Am Heart J; 2015 Mar; 169(3):315-22. PubMed ID: 25728720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.